CREB5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.168030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.484330E-02
Normal-vs-Stage2
1.29140000004746E-06
Normal-vs-Stage3
8.990400E-02
Normal-vs-Stage4
7.388100E-02
Stage1-vs-Stage2
8.321000E-01
Stage1-vs-Stage3
1.382230E-01
Stage1-vs-Stage4
7.115800E-01
Stage2-vs-Stage3
4.01900000002176E-06
Stage2-vs-Stage4
5.219800E-01
Stage3-vs-Stage4
2.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.129610E-01
Normal-vs-AfricanAmerican
3.550000E-01
Normal-vs-Asian
5.155900E-03
Caucasian-vs-AfricanAmerican
2.626000E-01
Caucasian-vs-Asian
4.336200E-01
AfricanAmerican-vs-Asian
3.556400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.71411999999593E-05
Normal-vs-Female
1.239760E-01
Male-vs-Female
2.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.630300E-02
Normal-vs-Age(41-60Yrs)
7.214200E-04
Normal-vs-Age(61-80Yrs)
1.082650E-01
Normal-vs-Age(81-100Yrs)
1.067750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.641200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.042800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.764200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.587530E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.877900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.250210E-01
Normal-vs-Daily Drinker
9.048200E-02
Normal-vs-Weekly Drinker
1.116790E-01
Normal-vs-Occasional Drinker
1.110570E-01
Normal-vs-Social Drinker
1.245150E-01
Non Drinker-vs-Daily Drinker
3.216900E-03
Non Drinker-vs-Weekly Drinker
4.165800E-01
Non Drinker-vs-Occasional Drinker
3.815600E-01
Non Drinker-vs-Social Drinker
9.622600E-01
Daily Drinker-vs-Weekly Drinker
1.570030E-01
Daily Drinker-vs-Occasional Drinker
1.157580E-01
Daily Drinker-vs-Social Drinker
3.480200E-03
Weekly Drinker-vs-Occasional Drinker
9.964600E-01
Weekly Drinker-vs-Social Drinker
4.446200E-01
Occasional Drinker-vs-Social Drinker
4.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.472400E-01
Normal-vs-Grade 2
3.767000E-01
Normal-vs-Grade 3
4.173200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.819800E-01
Grade 1-vs-Grade 3
4.666000E-01
Grade 1-vs-Grade 4
5.472400E-01
Grade 2-vs-Grade 3
7.903000E-01
Grade 2-vs-Grade 4
3.767000E-01
Grade 3-vs-Grade 4
4.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.47340000000462E-05
Normal-vs-NonDiabetic
1.155850E-01
Diabetic-vs-NonDiabetic
6.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.364960E-03
Normal-vs-NoPancreatitis
1.125020E-01
Pancreatitis-vs-NoPancreatitis
7.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.099950E-01
Normal-vs-N1
2.38210000003125E-06
N0-vs-N1
2.790400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.059810E-01
Normal-vs-TP53-NonMutant
1.114620E-01
TP53-Mutant-vs-TP53-NonMutant
6.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
